Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 13 for:    toca
Previous Study | Return to List | Next Study

A Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care (Toca7)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02598011
Recruitment Status : Withdrawn (Sponsor decision)
First Posted : November 5, 2015
Last Update Posted : March 30, 2020
Information provided by (Responsible Party):
Tocagen Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2022
Study Completion Date : No date given